Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Sunitinib 5ripretinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Biopsy 2regorafenib 1binimetinib 1Temozolomide 1TAS-116 1Sorafenib 1Rogaratinib 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Midazolam 1Ipilimumab 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Stromal Tumors × TAS-116 × Clear all
NCT05245968 2026-01-20

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Taiho Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
78 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡